4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000137
Chairperson & CEO sold 9,500 shares at an average $499.03 ($4,740,795)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-09-08 | Sale : show line 2 in the form 10b5-1 | −40 | $481.91 | $19,276 | 333,903 | I |
| 2026-09-08 | Sale : show line 3 in the form 10b5-1 | −200 | $483.90 | $96,780 | 333,703 | I |
| 2026-09-08 | Sale : show line 4 in the form 10b5-1 | −220 | $491.04 | $108,028 | 333,483 | I |
| 2026-09-08 | Sale : show line 5 in the form 10b5-1 | −140 | $492.72 | $68,980 | 333,343 | I |
| 2026-09-08 | Sale : show line 6 in the form 10b5-1 | −144 | $493.98 | $71,133 | 333,199 | I |
| 2026-09-08 | Sale : show line 7 in the form 10b5-1 | −600 | $494.87 | $296,923 | 332,599 | I |
| 2026-09-08 | Sale : show line 8 in the form 10b5-1 | −256 | $495.75 | $126,912 | 332,343 | I |
| Open-market sales · 9,500 sh · avg $499.03 · $4,740,795 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-08 | Exercise or conversion : show line 17 in the form 10b5-1 Stock Option | −9,500 | 480,410 | I |
Loading xslF345X06/primarydocument.xml…